logo
Plus   Neg
Share
Email

Cisco, Samsung In Patent Cross-License Deal

Cisco Systems, Inc. (CSCO) and South Korea's Samsung Electronics Co., Ltd. said Wednesday that they have entered into a patent cross-license agreement, effective immediately.

Both companies gain access to each other's industry-leading patent portfolios under the agreement, which covers a broad range of products and technologies. The mutually beneficial agreement covers the two companies' existing patents as well as those filed over the next 10 years.

This type of patent agreement reduces the risk of potential litigation and instead puts the focus on innovation for future products and services, the companies noted.

"Innovation is stifled all too often in today's overly-litigious environment," said Dan Lang, Cisco's Vice President of Intellectual Property. "By cross-licensing our patent portfolios, Cisco and Samsung are taking important steps to reverse the trend and advance innovation and freedom of operation."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic. AstraZeneca Plc and Oxford University's coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately prepare regulatory submission of the data to worldwide authorities for conditional or early approval. The company will also ask for an Emergency Use Listing from the WHO.
Follow RTT